Immune Cell Therapy

CIK cytokine-induced killer cells

A preparation of autologous lymphocytes with potential immunopotentiating and antineoplastic activities.

Cytokine-induced killer (CIK) cells are CD3-and CD56-positive, non-major histocompatibility complex (MHC)-restricted, natural killer (NK)-like T lymphocytes, generated ex-vivo by incubation of peripheral blood lymphocytes (PBL's) with anti-CD3 monoclonal antibody, interleukin (IL)-2, IL-1, and interferon gamma (IFN-gamma) and then expanded.

When reintroduced back to patients after autologous stem cell transplantation, CIK cells may recognize and kill tumor cells.

CIK cells have enhanced cytotoxic activity compared to lymphokine-activated killer (LAK) cells.

DC dentritic cells

These cells act as the quarterbacks of the immune system and coordinate the system's attack against foreign invaders.

CIK-Pack Therapy

A combined daily infusion of first a generous amount of dentritic cells who have the ability to mark foreign cells as 'non-self' followed by at least one billion (1.000.000.000) Cytokine-induced killer (CIK) cells, able to fight the equivalent of one cubic centimeter 1 cm³ of tumor/cancer cells.

The 5-year survival rate and non-recurrence of all kinds of cancers is 67% !

CIK-Pack Therapy is only available in China, it is safe and highly recommended.

-book your CIK-pack treatment through WAHSA and you will be given VIP status in China-